CS
IBB icon

Comerica Securities’s iShares Biotechnology ETF IBB Stock Holding History

Comerica Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,277
Closed -$243K – 407
2017
Q4 		$243K Hold
2,277
– – 0.03% 375
2017
Q3 		$253K Sell
2,277
-666
-23% -$71.2K 0.04% 355
2017
Q2 		$304K Sell
2,943
-39
-1% -$3.84K 0.05% 314
2017
Q1 		$292K Sell
2,982
-477
-14% -$45.7K 0.05% 316
2016
Q4 		$306K Buy
3,459
+1,113
+47% +$101K 0.08% 267
2016
Q3 		$226K Buy
+2,346
New +$223K 0.04% 313
2015
Q3 		– Sell
-2,580
Closed -$317K – 341
2015
Q2 		$317K Buy
+2,580
New +$309K 0.08% 247

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Comerica Securities's IBB Position: Q1 2018 in Review

Comerica Securities sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 2,277 shares — an estimated $243K sold.

Comerica Securities first reported a position in IBB in Q2 2015 and held it in 7 quarters. The position peaked at $317K in Q2 2015. 607 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

  • Comerica Securities reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
  • Comerica Securities sold 2,277 iShares Biotechnology ETF shares in Q1 2018, an estimated $243K.
  • Comerica Securities first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 7 quarters.
  • Comerica Securities's iShares Biotechnology ETF position peaked at $317K in Q2 2015.
  • 607 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on Comerica Securities's 13F filing for Q1 2018, filed 7 May 2018.